Details of issuance or disposal
Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
Number of shares delivered during the month: 100,000 shares (new shares)
The lower thin line represents the existing number of shares to which these shares will be added.
0.7% (exercise ratio subject to the exercise limit; 100,000 shares delivered during the month / 14,942,292 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 100,000 shares (new shares) |
| Intended allottee | EVO FUND (allottee of the 11th Series Stock Acquisition Rights) |
| Dilution Rate | 0.7% (exercise ratio subject to the exercise limit; 100,000 shares delivered during the month / 14,942,292 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 16,101,892 shares (as of the end of the month preceding the relevant month, including 203,957 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥218, ¥207, ¥206, ¥197 and ¥195. Details of the adjustment clause are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 104,596; unexercised as of the end of the month preceding the relevant month: 93,000; unexercised as of month-end: 92,000 |
| Most recent equity financing | Timing 12 February 2026 / Type Issuance of the Eleventh Series of Stock Acquisition Rights / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these stock acquisition rights in May 2026.